|
14.12.20
|
|
Alexion Pharmaceuticals Outperform
|
RBC Capital Markets
|
|
07.08.18
|
|
Alexion Pharmaceuticals Hold
|
Stifel, Nicolaus & Co., Inc.
|
|
18.12.17
|
|
Alexion Pharmaceuticals Outperform
|
Robert W. Baird & Co. Incorporated
|
|
15.09.17
|
|
Alexion Pharmaceuticals Outperform
|
RBC Capital Markets
|
|
13.09.17
|
|
Alexion Pharmaceuticals Buy
|
Deutsche Bank AG
|
|
30.03.17
|
|
Alexion Pharmaceuticals Buy
|
UBS AG
|
|
02.03.17
|
|
Alexion Pharmaceuticals Buy
|
Instinet
|
|
17.02.17
|
|
Alexion Pharmaceuticals Outperform
|
RBC Capital Markets
|
|
|
|
22.12.16
|
|
Alexion Pharmaceuticals Outperform
|
RBC Capital Markets
|
|
03.11.16
|
|
Alexion Pharmaceuticals Buy
|
Deutsche Bank AG
|
|
13.07.16
|
|
Alexion Pharmaceuticals buy
|
SunTrust
|
|
13.07.16
|
|
Alexion Pharmaceuticals Outperform
|
RBC Capital Markets
|
|
29.04.16
|
|
Alexion Pharmaceuticals Outperform
|
BMO Capital Markets
|
|
08.04.16
|
|
Alexion Pharmaceuticals Market Perform
|
BMO Capital Markets
|
|
11.12.15
|
|
Alexion Pharmaceuticals Buy
|
Stifel, Nicolaus & Co., Inc.
|
|
31.07.15
|
|
Alexion Pharmaceuticals Buy
|
UBS AG
|
|
31.07.15
|
|
Alexion Pharmaceuticals Buy
|
Stifel, Nicolaus & Co., Inc.
|
|
31.07.15
|
|
Alexion Pharmaceuticals Buy
|
Brean Capital
|
|
07.05.15
|
|
Alexion Pharmaceuticals Buy
|
Brean Capital
|
|
30.01.15
|
|
Alexion Pharmaceuticals Buy
|
Stifel, Nicolaus & Co., Inc.
|
|
08.01.15
|
|
Alexion Pharmaceuticals Buy
|
UBS AG
|
|
25.10.12
|
|
Alexion Pharmaceuticals buy
|
UBS AG
|
|
27.07.12
|
|
Alexion Pharmaceuticals buy
|
Stifel, Nicolaus & Co., Inc.
|
|
26.07.12
|
|
Alexion Pharmaceuticals buy
|
UBS AG
|
|
10.05.12
|
|
Alexion Pharmaceuticals overweight
|
Barclays Capital
|
|
26.04.12
|
|
Alexion Pharmaceuticals overweight
|
Barclays Capital
|
|
23.02.12
|
|
Alexion Pharmaceuticals buy
|
UBS AG
|
|
13.02.12
|
|
Alexion Pharmaceuticals overweight
|
Barclays Capital
|
|
10.02.12
|
|
Alexion Pharmaceuticals outperform
|
Robert W. Baird & Co. Incorporated
|
|
24.01.12
|
|
Alexion Pharmaceuticals outperform
|
Oppenheimer & Co. Inc.
|
|
30.12.11
|
|
Alexion Pharmaceuticals overweight
|
Barclays Capital
|
|
29.12.11
|
|
Alexion Pharmaceuticals outperform
|
Leerink Swann LLC
|
|
28.09.11
|
|
Alexion Pharmaceuticals buy
|
Deutsche Bank Securities
|
|
27.09.11
|
|
Alexion Pharmaceuticals outperform
|
Oppenheimer & Co. Inc.
|
|
18.05.11
|
|
Alexion Pharmaceuticals buy
|
Goldman Sachs Group Inc.
|
|
25.03.11
|
|
Alexion Pharmaceuticals outperform
|
Oppenheimer & Co. Inc.
|
|
23.11.10
|
|
Alexion Pharmaceuticals buy
|
Needham & Company, LLC
|
|
25.10.10
|
|
Alexion Pharmaceuticals buy
|
Citigroup Corp.
|
|
21.10.10
|
|
Alexion Pharmaceuticals outperform
|
Oppenheimer & Co. Inc.
|
|
03.06.10
|
|
Alexion Pharmaceuticals kaufen
|
Oppenheimer & Co. Inc.
|
|
26.04.10
|
|
Alexion Pharmaceuticals kaufen
|
Goldman Sachs Group Inc.
|
|
20.04.10
|
|
Alexion Pharmaceuticals kaufen
|
UBS AG
|
|
08.10.09
|
|
Alexion Pharmaceuticals buy
|
Jefferies & Company Inc.
|
|
02.09.09
|
|
Alexion Pharmaceuticals buy
|
Citigroup Corp.
|
|
24.07.09
|
|
Alexion Pharmaceuticals outperform
|
Credit Suisse Group
|
|
24.07.09
|
|
Alexion Pharmaceuticals buy
|
Brean Murray, Carret & Co., LLC
|
|
13.07.09
|
|
Alexion Pharmaceuticals buy
|
UBS AG
|
|
12.06.09
|
|
Alexion Pharmaceuticals buy
|
Piper Jaffray & Co.
|
|
26.05.09
|
|
Alexion Pharmaceuticals outperform
|
Credit Suisse Group
|
|
03.04.09
|
|
Alexion Pharmaceuticals buy
|
Goldman Sachs Group Inc.
|
